![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Siva, Shankar; Ali, Muhammad; Correa, Rohann J. M.; Muacevic, Alexander; Ponsky, Lee; Ellis, Rodney J.; Lo, Simon S.; Onishi, Hiroshi; Swaminath, Anand; McLaughlin, Mark; Morgan, Scott C.; Cury, Fabio L.; Teh, Bin S.; Mahadevan, Anand; Kaplan, Irving D.; Chu, William; Grubb, William; Hannan, Raquibul; Staehler, Michael; Warner, Andrew und Louie, Alexander V.
(2022):
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
In: Lancet Oncology, Bd. 23, Nr. 12: S. 1508-1516
Siva, Shankar; Correa, Rohann J. M.; Warner, Andrew; Staehler, Michael; Ellis, Rodney J.; Ponsky, Lee; Kaplan, Irving D.; Mahadevan, Anand; Chu, William; Gandhidasan, Senthilkumar; Swaminath, Anand; Onishi, Hiroshi; Teh, Bin S.; Lo, Simon S.; Muacevic, Alexander und Louie, Alexander
(2020):
Stereotactic Ablative Radiotherapy for >= T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
In: International Journal of Radiation Oncology Biology Physics, Bd. 108, Nr. 4: S. 941-949
Siva, Shankar; Ellis, Rodney J.; Ponsky, Lee; Teh, Bin S.; Mahadevan, Anand; Muacevic, Alexander; Staehler, Michael; Onishi, Hiroshi; Wersall, Peter; Nomiya, Takuma und Lo, Simon S.
(2016):
Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma.
In: Future Oncology, Bd. 12, Nr. 5: S. 637-645